Sanofi introduces AVAXIM Junior in UK for Hepatitis A in children aged 1-15 years
The introduction of AVAXIM Junior in the UK was based on findings from 20 clinical studies in 14…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
24 Apr 23
The introduction of AVAXIM Junior in the UK was based on findings from 20 clinical studies in 14…
24 Apr 23
Interdepartmental cooperation is key to optimising the BSI workflow. The BD consultants have been working with the nursing,…
21 Apr 23
TPG will acquire a majority interest in the community oncology practice management platform, while AmerisourceBergen will buy a…
21 Apr 23
The investigation of antibodies against pathogenic agents in cerebrospinal fluid samples is an important tool in the diagnosis…
20 Apr 23
Faced with a rapidly increasing workload and the growing threat of antimicrobial resistance, clinical laboratories must find a…
19 Apr 23
Hizentra is said to be the first and only immune globulin treatment for primary immunodeficiency and chronic inflammatory…
19 Apr 23
Slow diagnosis can exacerbate sexually transmitted infections. What is needed is a fast and accurate method of diagnosing…
18 Apr 23
Neonatal sepsis affects a large amount of newborns, which is why it is imperative to identify as quickly…
17 Apr 23
The data from the late-stage study showed a statistically significant improvement in RFS in people with HCC at…
17 Apr 23
Genomic sequencing allows doctors to identify mistakes in the instructions that can lead to diseases, but what if…